Literature DB >> 1372882

Tumorigenicity, mucin production and AM-3 epitope expression in clones selected from the HT-29 colon carcinoma cell line.

C Hanski1, B Stolze, E O Riecken.   

Abstract

Two mucin-producing cell clones (16.2 and 12.2) and a mucin-deficient clone (15.2) were selected from the established human adenocarcinoma cell line HT-29 by limiting dilution and Alcian blue staining. The amounts of the mucin antigen detectable on the cell surface with the monoclonal antibody (MAb) AM-3 decreased in the order HT-29 greater than 16.2 greater than 12.2 greater than 15.2 = 0. The binding avidity of AM-3 antibody to cells as well as to mucin extracts from each cell line decreased in the same order, indicating that the epitope density on the cell-bound mucins was highest in HT-29 and lowest in 12.2 cells. The parental line and the mucin-producing cell clones 16.2 and 12.2 showed no contact inhibition and grew as aggregates, while the 15.2 cells were well spread and formed a regular monolayer. The mucin-producing cell lines injected into nude mice yielded solid tumors with different growth rates (HT-29 greater than 16.2 greater than 12.2), while the 15.2 cell clone was not tumorigenic at all. The relative amounts of total mucin-bound hexoses and of the mucin epitope AM-3 decreased in the xenografts in the order HT-29 greater than 16.2 greater than 12.2. The present system is suitable for investigating the role of mucins in growth of colon carcinoma cells and indicates that increased tumorigenicity in nude mice coincides with the increase in total mucin expression and the expression of the AM-3 mucin epitope in tumor tissue.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372882     DOI: 10.1002/ijc.2910500618

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  Fucosyltransferase III and sialyl-Le(x) expression correlate in cultured colon carcinoma cells but not in colon carcinoma tissue.

Authors:  C Hanski; E Klussmann; J Wang; C Böhm; D Ogorek; M L Hanski; S Krüger-Krasagakes; J Eberle; A Schmitt-Gräff; E O Riecken
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

2.  Control of CDH1/E-Cadherin Gene Expression and Release of a Soluble Form of E-Cadherin in SARS-CoV-2 Infected Caco-2 Intestinal Cells: Physiopathological Consequences for the Intestinal Forms of COVID-19.

Authors:  Ikram Omar Osman; Clémence Garrec; Gabriel Augusto Pires de Souza; Ana Zarubica; Djamal Brahim Belhaouari; Jean-Pierre Baudoin; Hubert Lepidi; Jean-Louis Mege; Bernard Malissen; Bernard La Scola; Christian Albert Devaux
Journal:  Front Cell Infect Microbiol       Date:  2022-05-04       Impact factor: 6.073

3.  Interferon-gamma inhibits enterocyte migration by reversibly displacing connexin43 from lipid rafts.

Authors:  Cynthia L Leaphart; Shipan Dai; Steven C Gribar; Ward Richardson; John Ozolek; Xia-hua Shi; Jennifer R Bruns; Maria Branca; Jun Li; Ora A Weisz; Chhinder Sodhi; David J Hackam
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-07-17       Impact factor: 4.052

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.